An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
2018年12月7日 更新者:Novo Nordisk A/S
This study is conducted in Europe.
The aim of the study is to gather information about hypoglycaemia (low blood glucose) among patients with Type 1 or Type 2 diabetes mellitus.
The study is both retrospective and prospective.
研究概览
研究类型
观察性的
注册 (实际的)
29304
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Copenhagen S、丹麦、2300
- Novo Nordisk Investigational Site
-
-
-
-
-
Kfar Saba、以色列、44425
- Novo Nordisk Investigational Site
-
-
-
-
-
Moscow、俄罗斯联邦、119330
- Novo Nordisk Investigational Site
-
-
-
-
-
Sofia、保加利亚、1407
- Novo Nordisk Investigational Site
-
-
-
-
-
Zagreb、克罗地亚、10 000
- Novo Nordisk Investigational Site
-
-
-
-
-
Mississauga、加拿大、L4W 4XI
- Novo Nordisk Investigational Site
-
-
-
-
-
Budapest、匈牙利、1025
- Novo Nordisk Investigational Site
-
-
-
-
-
Bangalore、印度、560001
- Novo Nordisk Investigational Site
-
-
-
-
-
Belgrade、塞尔维亚、11070
- Novo Nordisk Investigational Site
-
-
-
-
-
Mexico City、墨西哥
- Novo Nordisk Investigational Site
-
-
-
-
-
Vienna、奥地利、A-1010
- Novo Nordisk Investigational Site
-
-
-
-
-
Mainz、德国、55127
- Novo Nordisk Investigational Site
-
-
-
-
-
Prague、捷克语、16000
- Novo Nordisk Investigational Site
-
-
-
-
-
Bratislava、斯洛伐克、811 05
- Novo Nordisk Investigational Site
-
-
-
-
-
Ljubljana、斯洛文尼亚、SI-1000
- Novo Nordisk Investigational Site
-
-
-
-
-
Riyadh、沙特阿拉伯、3542
- Novo Nordisk Investigational Site
-
-
-
-
-
Warszawa、波兰、PL-02-274
- Novo Nordisk Investigational Site
-
-
-
-
-
Malmö、瑞典、202 15
- Novo Nordisk Investigational Site
-
-
-
-
-
Bucharest、罗马尼亚、010031
- Novo Nordisk Investigational Site
-
-
-
-
-
Espoo、芬兰、FI-02600
- Novo Nordisk Investigational Site
-
-
-
-
-
Alphen A/d Rijn、荷兰
- Novo Nordisk Investigational Site
-
-
-
-
-
Prov. De Buenos Aires、阿根廷、B1636DSU
- Novo Nordisk Investigational Site
-
-
-
-
-
Selangor Darul Ehsan、马来西亚
- Novo Nordisk Investigational Site
-
-
-
-
-
Amman、黎巴嫩、11844
- Novo Nordisk Investigational Site
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
不
有资格学习的性别
全部
取样方法
非概率样本
研究人群
Insulin-treated patients with Type 1 or Type 2 diabetes mellitus.
Patients should be ambulatory, literate, have used insulin for at least 12 months, and be over 18 years of age to be able to participate in the study.
描述
Inclusion Criteria:
- Patients with Type 1 or Type 2 diabetes mellitus treated with insulin for more than 12 months
- Patients giving informed consent to participate in the survey
Exclusion Criteria:
- Non-ambulatory patients
- Illiterate patients and patients otherwise unable to complete a written survey
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Insulin-treated patients with diabetes
|
Patients will be asked to complete a two-part patient self-assessment questionnaire (SAQ) comprising a retrospective cross-sectional evaluation (Part 1), and a prospective observational evaluation (Part 2).
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Incidence of any hypoglycaemic event
大体时间:In the 4 weeks prior to and following the baseline visit (Week 0)
|
In the 4 weeks prior to and following the baseline visit (Week 0)
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Difference in the reported incidence rates of any hypoglycaemia
大体时间:In the 4 weeks prior to (Part 1) versus following (Part 2) the baseline visit
|
In the 4 weeks prior to (Part 1) versus following (Part 2) the baseline visit
|
|
Incidence of hypoglycaemic events requiring hospital admission
大体时间:In the 6 months prior to and 4 weeks following the baseline visit
|
In the 6 months prior to and 4 weeks following the baseline visit
|
|
Incidence of all severe hypoglycaemic events
大体时间:In the 6 months prior to and 4 weeks following the baseline visit
|
In the 6 months prior to and 4 weeks following the baseline visit
|
|
Incidence of probable symptomatic hypoglycaemic events
大体时间:In the 4 weeks prior to and following the baseline visit
|
In the 4 weeks prior to and following the baseline visit
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Khunti K, Alsifri S, Aronson R, Cigrovski Berkovic M, Enters-Weijnen C, Forsen T, Galstyan G, Geelhoed-Duijvestijn P, Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A; HAT Investigator Group. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016 Sep;18(9):907-15. doi: 10.1111/dom.12689. Epub 2016 Jun 20.
- Khunti K, Alsifri S, Aronson R, Cigrovski Berkovic M, Enters-Weijnen C, Forsen T, Galstyan G, Geelhoed-Duijvestijn P, Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A; HAT Investigator Group. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2017 Aug;130:121-129. doi: 10.1016/j.diabres.2017.05.004. Epub 2017 May 12.
- Kern W, Holstein A, Moenninghoff C, Kienhofer J, Riedl M, Kulzer B. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study. Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):592-597. doi: 10.1055/s-0043-112350. Epub 2017 Jul 27.
- Pongrac Barlovic D, Zavratnik A, Skvarca A, Jansa K, Vukelic B, Tomazic M, Ravnik Oblak M. Self-reported Hypoglycaemia in Patients treated with Insulin: A Large Slovenian Retrospectively-prospective Study. Zdr Varst. 2017 Oct 9;56(4):244-250. doi: 10.1515/sjph-2017-0033. eCollection 2017 Oct.
- Aronson R, Goldenberg R, Boras D, Skovgaard R, Bajaj H. The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study. Can J Diabetes. 2018 Feb;42(1):11-17. doi: 10.1016/j.jcjd.2017.01.007. Epub 2017 May 17.
- Hussein Z, Kamaruddin NA, Chan SP, Jain A, Uppal S, Bebakar WMW; HAT study investigators in Malaysia. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: A cohort subanalysis of the HAT study. Diabetes Res Clin Pract. 2017 Nov;133:40-49. doi: 10.1016/j.diabres.2017.08.007. Epub 2017 Aug 14.
- Aronson R, Galstyan G, Goldfracht M, Al Sifri S, Elliott L, Khunti K. Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. Diabetes Res Clin Pract. 2018 Apr;138:35-43. doi: 10.1016/j.diabres.2018.01.007. Epub 2018 Jan 31.
- Haluzik M, Kretowski A, Strojek K, Czupryniak L, Janez A, Kempler P, Andel M, Tankova T, Boyanov M, Smircic Duvnjak L, Madacsy L, Tarnowska I, Zychma M, Lalic N. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes Ther. 2018 Apr;9(2):727-741. doi: 10.1007/s13300-018-0388-2. Epub 2018 Mar 9.
- de Groot S, Enters-Weijnen CF, Geelhoed-Duijvestijn PH, Kanters TA. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands. BMJ Open. 2018 Mar 25;8(3):e019864. doi: 10.1136/bmjopen-2017-019864.
- Khunti K, Cigrovski Berkovic M, Ludvik B, Moberg E, Barner Lekdorf J, Gydesen H, Pedersen-Bjergaard U. Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin-treated Type 2 diabetes mellitus. Diabet Med. 2018 May 5;35(9):1232-41. doi: 10.1111/dme.13662. Online ahead of print.
- Pedersen-Bjergaard U, Alsifri S, Aronson R, Berkovic MC, Galstyan G, Gydesen H, Lekdorf JB, Ludvik B, Moberg E, Ramachandran A, Khunti K. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies. Diabetes Obes Metab. 2019 Apr;21(4):844-853. doi: 10.1111/dom.13588. Epub 2018 Dec 17.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2012年9月5日
初级完成 (实际的)
2013年12月30日
研究完成 (实际的)
2013年12月30日
研究注册日期
首次提交
2012年9月26日
首先提交符合 QC 标准的
2012年9月27日
首次发布 (估计)
2012年9月28日
研究记录更新
最后更新发布 (实际的)
2018年12月11日
上次提交的符合 QC 标准的更新
2018年12月7日
最后验证
2018年12月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.